Free Trial

Healthpeak Properties, Inc. $DOC Shares Acquired by Hsbc Holdings PLC

Healthpeak Properties logo with Finance background

Key Points

  • Hsbc Holdings PLC has increased its stake in Healthpeak Properties by 5.1%, now owning approximately 0.33% of the firm valued at $46.25 million.
  • CEO Scott M. Brinker and Director Tommy G. Thompson have recently purchased shares, signaling confidence in the company's prospects, with insider purchases amounting to over $149,000 in total.
  • Healthpeak Properties has faced mixed reviews from analysts, with price targets being adjusted downwards; the current consensus rating is "Moderate Buy" with a target price of $22.10.
  • Want stock alerts on Healthpeak Properties? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Hsbc Holdings PLC increased its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 5.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,290,430 shares of the real estate investment trust's stock after buying an additional 111,142 shares during the period. Hsbc Holdings PLC owned about 0.33% of Healthpeak Properties worth $46,253,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Machina Capital S.A.S. increased its stake in shares of Healthpeak Properties by 62.8% in the first quarter. Machina Capital S.A.S. now owns 37,160 shares of the real estate investment trust's stock worth $751,000 after buying an additional 14,336 shares during the last quarter. Douglas Lane & Associates LLC increased its stake in shares of Healthpeak Properties by 8.5% in the first quarter. Douglas Lane & Associates LLC now owns 2,792,850 shares of the real estate investment trust's stock worth $56,471,000 after buying an additional 218,395 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its stake in shares of Healthpeak Properties by 6.9% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 357,520 shares of the real estate investment trust's stock worth $7,229,000 after buying an additional 23,135 shares during the last quarter. Ibex Wealth Advisors bought a new stake in shares of Healthpeak Properties in the first quarter worth $5,056,000. Finally, Vert Asset Management LLC increased its stake in shares of Healthpeak Properties by 6.9% in the first quarter. Vert Asset Management LLC now owns 325,143 shares of the real estate investment trust's stock worth $6,574,000 after buying an additional 20,924 shares during the last quarter. Institutional investors own 93.57% of the company's stock.

Insider Buying and Selling at Healthpeak Properties

In other news, CEO Scott M. Brinker purchased 2,930 shares of Healthpeak Properties stock in a transaction dated Thursday, July 31st. The stock was bought at an average price of $17.06 per share, with a total value of $49,985.80. Following the completion of the acquisition, the chief executive officer owned 210,416 shares in the company, valued at $3,589,696.96. The trade was a 1.41% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Tommy G. Thompson purchased 5,777 shares of Healthpeak Properties stock in a transaction dated Wednesday, May 28th. The shares were purchased at an average cost of $17.27 per share, with a total value of $99,768.79. Following the acquisition, the director owned 144,290 shares of the company's stock, valued at approximately $2,491,888.30. This trade represents a 4.17% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have bought 14,560 shares of company stock valued at $249,898. Corporate insiders own 0.23% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. Evercore ISI dropped their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Robert W. Baird set a $21.00 price target on shares of Healthpeak Properties and gave the stock an "outperform" rating in a research note on Wednesday, July 30th. Scotiabank lowered shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and lowered their target price for the company from $21.00 to $19.00 in a research note on Tuesday, July 29th. Wall Street Zen lowered shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Finally, Wells Fargo & Company lowered their target price on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research note on Monday, June 2nd. Seven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat, Healthpeak Properties has a consensus rating of "Moderate Buy" and a consensus price target of $22.10.

Read Our Latest Stock Report on Healthpeak Properties

Healthpeak Properties Stock Up 0.4%

DOC stock opened at $17.2850 on Friday. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28. Healthpeak Properties, Inc. has a 1-year low of $16.63 and a 1-year high of $23.26. The firm has a fifty day moving average price of $17.61 and a two-hundred day moving average price of $18.40. The firm has a market cap of $12.01 billion, a price-to-earnings ratio of 72.02, a PEG ratio of 2.20 and a beta of 1.05.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The firm had revenue of $694.35 million during the quarter, compared to analyst estimates of $697.14 million. During the same quarter in the previous year, the firm earned $0.45 earnings per share. The firm's revenue for the quarter was down .2% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Research analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The company also recently declared a dividend, which will be paid on Friday, August 29th. Stockholders of record on Tuesday, August 19th will be issued a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, August 18th. This represents a dividend yield of 705.0%. Healthpeak Properties's payout ratio is 508.33%.

Healthpeak Properties Profile

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Featured Articles

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines